GINBIO has always followed its core values of “Integrity, Innovation, Compassion” and the corporate mission of “Commitment to Novel Therapeutics Development and Dedication to Human Lifestyle Improvement”, devoting itself to developing innovative new drugs.
Upholding the spirit of innovation in research and development of technology, GINBIO has integrated the resources from industry, academic and government and actively developed international drugs. Conforming to its prudent business strategy, the company has gradually expanded four major biotech operational areas covering new drugs, health products, investment and sales channels.
Looking to the future, GINBIO will be creating blue oceans of uncontested market space with its innovation competences and with honest alliances. Sharing love with the society, the company has been developing world-class biotech drugs with its strong and solid foundation. GINBIO has strived to create benefits for shareholders and to make the maximum contribution to human well-being and life care.